ATA Guidelines Tools

Thyroid Disease During Pregnancy

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/789888

Contents of this Issue

Navigation

Page 18 of 19

19 Î Breastfed children of women who are treated with antithyroid drugs should be monitored for appropriate growth and development during routine pediatric health and wellness evaluations. Routine assessment of serum thyroid function in the child is NOT recommended. (W-M) Î All breastfeeding women should ingest approximately 250 mcg of dietary iodine daily. (S-H) Î Breastfeeding women should supplement their diet with a daily oral supplement that contains 150 mcg of iodine. This is optimally delivered in the form of potassium iodide (present in a multivitamin) because kelp and other forms of seaweed do not provide a consistent delivery of daily iodine. (S-M) Î In severely iodine deficient, low-resource regions, where universal salt iodization is lacking and daily supplementation is not feasible, lactating women should receive one dose of 400 mg iodine as oral iodized oil soon after delivery. (S-H) Î As is the case during pregnancy, sustained iodine intake while breastfeeding that exceeds 500–1100 mcg daily should be avoided due to concerns about the potential for inducing hypothyroidism in the infant. (S-M)

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease During Pregnancy